CIK 0001528287
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
NeuroPace Inc
Sign in to watch- Ticker
- NPCE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 223550230
- Phone
- +1 650-237-2700
- Business address
- 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-26 | Favet Michael Chief Executive Officer | Conversion · Series A' Preferred Stock | −343 | 0 | ||
| 2021-04-26 | Favet Michael Chief Executive Officer | Conversion · Series B' Preferred Stock | −7,219 | 0 | ||
| 2021-04-26 | LACOB JOSEPH Director | Grant or award | +334,027 | 351,920 | ||
| 2021-04-26 | LACOB JOSEPH Director | Conversion · Series A' Preferred Stock | −8,594 | 0 | ||
| 2021-04-26 | LACOB JOSEPH Director | Conversion · Series A' Preferred Stock | −17,189 | 0 | ||
| 2021-04-26 | LACOB JOSEPH Director | Conversion · Series B; Preferred Stock | −102,747 | 0 | ||
| 2021-04-26 | LACOB JOSEPH Director | Conversion · Series B' Preferred Stock | −205,497 | 0 | ||
| 2021-04-26 | KCK LTD. 10% owner | Conversion | +5,595,493 | 5,621,111 | ||
| 2021-04-26 | KCK LTD. 10% owner | Conversion · Series A' Prime Preferred Stock | −323,591 | 0 | ||
| 2021-04-26 | KCK LTD. 10% owner | Conversion · Series B' Prime Preferred Stock | −5,271,902 | 0 | ||
| 2021-04-21 | Ryan Renee Director | Grant or award · Stock Option (Right to Buy) | +21,698 | 21,698 | ||
| 2021-04-21 | Norton Evan Director | Grant or award · Stock Option (Right to Buy) | +21,698 | 21,698 | ||
| 2021-04-21 | Kumar Rakhi Director | Grant or award · Stock Option (Right to Buy) | +21,698 | 21,698 | ||
| 2021-04-21 | LACOB JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +21,698 | 21,698 | ||
| 2021-04-21 | ORBIMED ADVISORS LLC 10% owner | Purchase | +235,000 | $17.00 | $4.0M | 235,000 |
| 2021-04-21 | Ridley Irina General Counsel and Secretary | Purchase | +2,352 | $17.00 | $40K | 2,352 |
| 2021-04-21 | Accelmed Partners II L.P. 10% owner | Purchase | +588,235 | $17.00 | $10.0M | 588,235 |
| 2021-04-21 | Fischer Frank M Director | Purchase | +50,000 | $17.00 | $850K | 93,291 |
| 2021-04-21 | Fischer Frank M Director | Grant or award · Stock Option (Right to Buy) | +21,698 | 21,698 | ||
| 2021-04-21 | Garfield Greg Shaw Director | Purchase | +13,235 | $17.00 | $225K | 38,853 |
Page 18 of 19 · 362 trades